Figure 4.
Biosimilar penetration for infliximab and etanercept in Germany over time. Biosimilar market shares (%) are calculated as volume of biosimilars over volume of biosimilars plus the originator product (DDDs).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.